Proteomics International Laboratories Ltd (ASX:PIQ)is a medical technology company specialising in precision diagnostics and bio-analytical services. It operates under the trading name Proteomics International and is a wholly owned subsidiary of PILL.

Team Kalkine | 20 Jun 2025| Read Time : 10 Mins

News

Optiscan Shares Jump On Monday Following Exclusive Collaboration with Long Grove Pharmaceuticals

PointsBet Endorses $1.20 MIXI Offer, Questions Betr's Scrip Takeover Proposal

Metcash Hits 52-Week High as Full-Year Revenue Rises 8.9% and Food Segment Drives EBIT Growth

ASX Outliers: Betr, Centuria, and GR Engineering Defy Market Slump

SEEK Secures BUY Rating With 15% Upside. Here's Why.

BUY Rating Brings Step One Clothing (ASX:STP) to Limelight Amid 100% Upside Potential

Proteomics International Launches PromarkerD Test in US at ADA Conference

Premium News

Metcash (ASX: MTS) eyes acquisition of complementary businesses, opening new stores

Sonic Healthcare (ASX: SHL) downgrades FY24 EBITDA guidance on inflationary pressure, forex volatility

Cettire (ASX: CTT) set to debut in China in 4QFY24 to boost revenue growth

Woolworths Group (ASX: WOW) expects 2HFY24 EBIT growth to be lower than 1HFY24

Frontier Energy (ASX: FHE) focuses on advancing largest renewable energy project in Australia

Accent Group (ASX: AX1) plans to open 20 new stores in H2FY24

Light & Wonder (ASX: LNW) banks on new hardware and content launches to drive 2024 revenue growth